| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $293K | — | -84.8% |
| R&D Expense | $32.0M | — | -2.4% |
| SG&A Expense | $8.9M | — | -4.7% |
| Operating Income | -$40.8M | — | +1.9% |
| Interest Expense | $2.8M | — | -6.4% |
| Income Tax | $0 | — | — |
| Net Income | -$46.3M | — | -15.8% |
| EPS (Basic) | -$0.57 | — | -11.8% |
| EPS (Diluted) | -$0.57 | — | -11.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $71.5M | +8.5% | +7.5% |
| Accounts Receivable | $3.3M | +8.8% | +344.6% |
| Current Assets | $96.2M | +4.8% | +20.4% |
| Total Assets | $244.7M | +0.1% | +9.2% |
| Current Liabilities | $176.1M | +43.7% | +236.3% |
| Total Liabilities | $302.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $17.8M | — | +148.4% |
| Capital Expenditures | $2.0M | — | +17.4% |
| Investing Cash Flow | -$2.3M | — | -32.0% |
| Financing Cash Flow | -$10.1M | — | -690.4% |
| Free Cash Flow | $15.8M | — | +141.0% |
| +58.6% |
| Stockholders' Equity | -$58.1M | -903.5% | -275.6% |